Is the risk as substantial as was initially reported?
Read More »Technology’s Evolving Role in Depression
A high percentage of people with diabetes also suffer from depression, and professionals need to be aware of things that they can do to help.
Read More »Following the Effects of COVID-19 Quarantine on Glucose Management
With stay-at-home orders, daily routines for many diabetes patients have been disrupted, creating concerns over the possible consequences of added stress, isolation, and elevated blood sugars.
Read More »Depression and Hyperglycemic Crisis
People who have diabetes and depression have a higher risk of complications from both diseases.
Read More »Lower Treatment Rates of Depression For Some Type 2 Patients
Does being a member of a minority ethnicity put you at risk of being overlooked for depression?
Read More »Why Monthly Lifestyle Counseling For Patients with Diabetes?
Regular lifestyle counseling can have positive long term clinical outcomes in patients with diabetes.
Read More »Depression + Diabetes = Increased Risk for Cardiovascular Outcomes
Patients who have diabetes should be screened for psychological risk factors.
Read More »The Importance of Routine Depression Screening in Patients with Type 1 Diabetes
Patients with diabetes are two times more likely to present with symptoms of depression; how does this affect diabetes outcomes?
Read More »Antidepressants Reduce Mortality For Patients With Diabetes And Depression
Both type 1 and type 2 diabetes increase the risk of depression.
Read More »Paula Trief 2018 Complete Interview
Paula Trief, PhD received her PhD in Clinical Psychology from Syracuse University. She joined the faculty at SUNY Upstate Medical University in the Department of Psychiatry & Behavioral Sciences in 1993. She is currently a tenured Distinguished Service Professor of Psychiatry & Behavioral Sciences, with joint appointments in the departments of Medicine and Orthopedic Surgery. Academically, she is an active behavioral science researcher, studying behavioral interventions for patients with diabetes. Her current RO1 studies factors that predict medication adherence and healthcare usage in emerging adults with type 2 diabetes.
Read More »